BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16036292)

  • 1. Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum.
    Sönmezer M; Atabekoğlu C; Cengiz B; Dökmeci F; Cengiz SD
    Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):9-14. PubMed ID: 16036292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot medroxyprogesterone acetate contraception. Metabolic parameters and mood changes.
    Westhoff C
    J Reprod Med; 1996 May; 41(5 Suppl):401-6. PubMed ID: 8725702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
    Mishell DR
    J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant therapy after prosthetic valve replacement -optimal PT-INR in Japanese patients-.
    Mori T; Asano M; Ohtake H; Bitoh A; Sekiguchi S; Matsuo Y; Aiba M; Yamada M; Kawada T; Takaba T
    Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):83-7. PubMed ID: 12027793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
    Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct].
    Kremer J; de Bruijn HW; Hindriks FR
    Ned Tijdschr Geneeskd; 1981 Aug; 125(35):1418-21. PubMed ID: 6456421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting injectable contraception with depot medroxyprogesterone acetate.
    Kaunitz AM
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P; Bottazzi M; Steel SA
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.
    Arias RD; Jain JK; Brucker C; Ross D; Ray A
    Contraception; 2006 Sep; 74(3):234-8. PubMed ID: 16904417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective review of the relationship between weight change and demographic factors following initial depot medroxyprogesterone acetate injection in adolescents.
    Gerlach LS; Saldaña SN; Wang Y; Nick TG; Spigarelli MG
    Clin Ther; 2011 Feb; 33(2):182-7. PubMed ID: 21397330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Our inability to predict thromboembolic events after prosthetic valve surgery.
    Will MB; Bernacca GM; Bell EF; Tolland MM; Lowe GD; Rumley A; Murray HM; Ford I; Wheatley DJ
    J Heart Valve Dis; 2006 Jul; 15(4):570-80; discussion 580. PubMed ID: 16901057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis--a pilot study.
    Walch K; Unfried G; Huber J; Kurz C; van Trotsenburg M; Pernicka E; Wenzl R
    Contraception; 2009 Jan; 79(1):29-34. PubMed ID: 19041438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.